Duration of treatment for osteoporosis

• Egile Nagusiak: Luca Idolazzi (Egilea), A. Fassio (Egilea), D. Gatti (Egilea), S. Tamanini (Egilea), O. Viapiana (Egilea), M. Rossini (Egilea), S. Adami (Egilea)
• Formatua: Liburua
• Argitaratua: PAGEPress Publications, 2013-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Many treatments for postmenopausal osteoporosis with proven efficacy in lowering fracture risk had become available since many years now. In the last few years the issue about treatment duration has become a matter of importance. In this paper the pivotal trials for alendronate, risedronate, zoledro...